NCT Number: NCT01180491
A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis
The purpose of this study is to further evaluate and document early visible effects on nail appearance of topical K101.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male or female patients aged 18 years or older
- 25%-75% of the target nail altered as a result of onychomycosis
- Signed written informed consent
Exclusion criteria
- Proximal subungual onychomycosis
- Patient who has been previously randomized to treatment in the phase III study K70-2 investigating K101
- Other conditions known to cause abnormal nail appearance
- Use of topical (1 month before screening) and/or systemic (3 months before screening) antifungal medication.
- Participation in another clinical study with an investigational drug or device during the previous 4 weeks before enrolment.
- Known allergy to any of the tested treatment products
Treatment and study plan
Primary outcomes
-
Proportion of patients experiencing at least some improvement of the target nail (scoring 2 or more according to Global Assessment Scale) after 8 weeks treatment.
Sponsors and collaborators
Lead sponsor
Moberg Pharma AB
Industry
Registry information
Important dates
- Study start
- 2010
- Primary completion
- 2010
- Study completion
- 2010
- First posted
- Aug 12, 2010
- Registry last updated
- Jun 26, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation of a Combination of Two Medical Devices and One Device Use in the Treatment of Toenail Onychomycosis
NCT06175013
Bacterial Infections and Mycoses, Dermatomycoses
Quatres Bornes, Mauritius
View Trial DetailsAn Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection
NCT05202366
Bacterial Infections and Mycoses, Dermatomycoses
Fort Worth, Texas, United States
View Trial DetailsSpread of Dermatophytes Among Families
NCT00233493
Bacterial Infections and Mycoses, Dermatomycoses
Cleveland, Ohio, United States
View Trial DetailsHuman Factors Testing for OTC Use of the Erchonia® LunulaLaser
NCT05626270
Bacterial Infections and Mycoses, Dermatomycoses
Melbourne, Florida, United States
View Trial Details